[go: up one dir, main page]

GB201007957D0 - Antibody - Google Patents

Antibody

Info

Publication number
GB201007957D0
GB201007957D0 GBGB1007957.2A GB201007957A GB201007957D0 GB 201007957 D0 GB201007957 D0 GB 201007957D0 GB 201007957 A GB201007957 A GB 201007957A GB 201007957 D0 GB201007957 D0 GB 201007957D0
Authority
GB
United Kingdom
Prior art keywords
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB1007957.2A
Other versions
GB2480298A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SECR DEFENCE
UK Secretary of State for Defence
Original Assignee
SECR DEFENCE
UK Secretary of State for Defence
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SECR DEFENCE, UK Secretary of State for Defence filed Critical SECR DEFENCE
Priority to GB1007957A priority Critical patent/GB2480298A/en
Publication of GB201007957D0 publication Critical patent/GB201007957D0/en
Publication of GB2480298A publication Critical patent/GB2480298A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/40—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1278—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Bacillus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • C12N5/163—Animal cells one of the fusion partners being a B or a T lymphocyte
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GB1007957A 2010-05-13 2010-05-13 Antibodies against Bacillus anthracis Withdrawn GB2480298A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB1007957A GB2480298A (en) 2010-05-13 2010-05-13 Antibodies against Bacillus anthracis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1007957A GB2480298A (en) 2010-05-13 2010-05-13 Antibodies against Bacillus anthracis

Publications (2)

Publication Number Publication Date
GB201007957D0 true GB201007957D0 (en) 2010-06-30
GB2480298A GB2480298A (en) 2011-11-16

Family

ID=42334685

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1007957A Withdrawn GB2480298A (en) 2010-05-13 2010-05-13 Antibodies against Bacillus anthracis

Country Status (1)

Country Link
GB (1) GB2480298A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9732145B2 (en) 2014-07-31 2017-08-15 The Israel Institute of Biological Research (IIBR) Antibodies directed to Bacillus anthracis protective antigen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005120567A2 (en) * 2004-03-03 2005-12-22 Iq Corporation Human anthrax toxin neutralizing monoclonal antibodies and methods of use thereof
WO2007084107A2 (en) * 2004-12-22 2007-07-26 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Monoclonal antibodies that neutralize anthrax protective antigen (pa) toxin
US8962278B2 (en) * 2005-08-03 2015-02-24 Ibio Inc. Compositions and methods for production of immunoglobulins

Also Published As

Publication number Publication date
GB2480298A (en) 2011-11-16

Similar Documents

Publication Publication Date Title
HUS1900020I1 (en) Cgrp antibodies
IL259826A (en) Anti-alphabetatcr antibody
HUE040213T2 (en) Anti-tim-3 antibody
LT3342786T (en) Anti-dll3 antibody
PL2616489T3 (en) Anti-hutnfr1 antibody
ZA201209004B (en) Anti-fgfr2 antibodies
GB201000467D0 (en) Antibodies
IL221371A0 (en) Anti-lrp6 antibodies
ZA201307983B (en) Anti-b7-h3 antibody
GB201103955D0 (en) Antibodies
GB201112056D0 (en) Antibodies
IL225667A0 (en) Novel antigen
GB201020738D0 (en) Antibodies
PL2603528T3 (en) Fab-glycosylated antibodies
ZA201302459B (en) Antibodies
GB201002238D0 (en) Antibodies
TWI563004B (en) Anti-hxcr1 antibody
EP2714074A4 (en) Anti-emr1 antibodies
GB201007957D0 (en) Antibody
GB201017780D0 (en) Antibody
GB201020751D0 (en) Antibodies
GB201005062D0 (en) Antibodies

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)